Headaches linked to the autonomic nervous system (ANS) fall into two broad camps: headaches that activate autonomic pathways as part of the attack itself, and headaches caused by a malfunctioning autonomic system elsewhere in the body. The first group, formally called trigeminal autonomic cephalalgias, includes cluster headache and several rarer conditions that produce severe one-sided head pain alongside symptoms like a tearing eye, a drooping eyelid, or a stuffy nose. The second group shows up in people with conditions like postural tachycardia syndrome (POTS) or orthostatic hypotension, where the headache is a downstream consequence of blood pressure or blood flow going haywire. Understanding which type you’re dealing with matters because the treatments are completely different.
How the Autonomic Nervous System Gets Involved in Head Pain
The autonomic nervous system controls things you don’t consciously manage: heart rate, blood vessel diameter, sweating, tear production, nasal congestion. In certain headache types, a reflex arc running through the brainstem fires abnormally, linking the trigeminal nerve (which carries pain signals from the face and head) to parasympathetic outflow (which controls glands and blood vessels in the face). Animal research has shown that stimulating a brainstem region called the superior salivatory nucleus activates both pain-signaling neurons and cranial autonomic responses at the same time, suggesting that brainstem activation may drive both the pain and the autonomic symptoms in these disorders.1Brain. A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization This is why someone having a cluster headache attack doesn’t just feel terrible pain on one side of the head; they also get a red, watering eye and a blocked nostril on the same side. The pain and the autonomic features are produced by the same circuit.
Cluster Headache
Cluster headache is the most well-known autonomic headache and one of the most painful conditions in medicine. Attacks produce excruciating, strictly one-sided pain usually centered around or behind one eye, lasting anywhere from 15 minutes to three hours. They tend to arrive in bouts, or “clusters,” that last weeks to months, separated by remission periods that can stretch for a year or more. During a cluster period, attacks often follow a strikingly regular schedule, frequently hitting at the same time each night.
That clockwork quality isn’t coincidental. The hypothalamus, a brain structure that serves as the body’s master clock, is believed to modulate cluster headache attacks. The severe pain and autonomic features are driven by abnormal activity in the trigeminal-autonomic reflex, and the temporal pattern of the attacks points to involvement of the biological clock, with the seasonal pattern influenced by changes in daylight hours.2PubMed. The biological clock in cluster headache: A review and hypothesis Brain imaging during attacks has confirmed increased functional connectivity between the hypothalamus and regions involved in pain processing, emotion, and attention, including the anterior cingulate cortex, the amygdala, and the frontal gyrus.3PLoS ONE. Abnormal Brain Functional Connectivity of the Hypothalamus in Cluster Headaches
The accompanying autonomic symptoms are what set cluster headache apart from other severe headaches. On the side of the pain, you may notice any combination of tearing, redness of the eye, nasal congestion or a runny nose, eyelid drooping, facial sweating, or a constricted pupil. These features are not optional extras; they’re part of the same trigeminal-autonomic reflex that generates the pain. Blood sampling during attacks has shown release of calcitonin gene-related peptide (CGRP), a molecule closely tied to head pain, along with vasoactive intestinal peptide (VIP), which is associated specifically with the facial autonomic symptoms like nasal congestion and tearing.4European Journal of Neurology. Neuropeptides in headache
Paroxysmal Hemicrania, SUNCT, and SUNA
Cluster headache is the most common trigeminal autonomic cephalalgia, but it has several rarer cousins that share the signature combination of one-sided pain plus autonomic symptoms. Paroxysmal hemicrania produces attacks that are shorter than cluster headache (typically 2 to 30 minutes) but more frequent, sometimes occurring dozens of times a day. Like cluster headache, neuroimaging shows posterior hypothalamic activation during attacks, suggesting the same central generator is at work.5PubMed Central. Paroxysmal Hemicrania The hallmark of paroxysmal hemicrania is its absolute response to the anti-inflammatory drug indomethacin; if indomethacin doesn’t work, the diagnosis is reconsidered.
SUNCT (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing) and SUNA (short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms) sit at the far end of the spectrum: extremely brief, stabbing attacks lasting seconds to a few minutes, often occurring many times per day.6PubMed. SUNCT and SUNA: clinical features and medical treatment In a large clinical series that characterized the conditions in detail, three distinct attack patterns were identified: single stabs, groups of stabs, and saw-tooth attacks where pain oscillates rapidly.7Brain. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)—a prospective clinical study of SUNCT and SUNA Both are considered rare and can be difficult to diagnose because the attacks are so fleeting that patients sometimes struggle to describe them to a doctor. The autonomic features in SUNCT are more prominent (eye redness and tearing are required for the diagnosis), while SUNA allows a broader range of autonomic signs.
When Migraine Mimics Autonomic Headaches
Here’s where things get confusing for patients and doctors alike: migraine can produce autonomic symptoms too. A significant proportion of people with migraine report tearing, nasal congestion, or eyelid swelling during attacks, which can make them look like they have a trigeminal autonomic cephalalgia when they don’t. The overlap is genuine, and studies of migraine patients have found that autonomic dysfunction is measurable between attacks as well, with most evidence pointing toward impaired sympathetic function and a lesser degree of parasympathetic impairment. Migraine with aura tends to produce more pronounced autonomic disturbances than migraine without aura.8PubMed. Migraine and Autonomic Dysfunction: Which Is the Horse and Which Is the Jockey?
The practical question is how to tell them apart. Research comparing autonomic features in migraine versus cluster headache has identified several reliable patterns. In migraine, autonomic symptoms tend to be bilateral rather than strictly on one side, they aren’t confined to the side of the headache, they’re milder in intensity, and they don’t consistently appear with every attack. In cluster headache, the autonomic features are ipsilateral (same side as the pain), prominent, and reliably present during attacks.9PubMed. Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache A large study of nearly 3,000 migraine patients and 93 cluster headache patients found that the combination of lacrimation, facial swelling, and conjunctival injection could distinguish migraine with underlying autonomic symptoms from other migraine with high sensitivity and specificity.10PubMed Central. Cranial Autonomic Features in Migraine and Migrainous Features in Cluster Headache
Getting this distinction right matters because the treatments are different. A person with cluster headache needs oxygen therapy and triptans for acute attacks and typically a preventive like verapamil. A person with migraine and prominent autonomic features still responds best to standard migraine treatments. Misdiagnosis in either direction means delayed relief.
Headaches from Dysautonomia
The headaches described so far activate autonomic pathways as part of the attack. But a separate category of ANS-related headache comes from the autonomic nervous system itself being dysfunctional throughout the body, with headache as a consequence rather than a cause of autonomic activation.
In POTS, standing up causes the heart rate to spike because the autonomic system fails to properly regulate blood vessel tone. Among the symptoms are lightheadedness, visual changes, fatigue, and headache. Research has shown that people with POTS have less effective regulation of blood flow to the brain when upright, with blood flow dropping more steeply and taking longer to stabilize compared to healthy controls.11PubMed Central. Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome The headache in POTS tends to be positional: worse when standing, better when lying down. It’s driven by reduced blood delivery to the brain rather than by a trigeminal-autonomic reflex.
Orthostatic hypotension, where blood pressure drops significantly on standing, produces a characteristic pattern sometimes called “coat-hanger pain”: aching in the back of the neck, the shoulders, and the suboccipital region, in a distribution that traces the shape of a coat hanger. This neck pain is frequently reported in patients with autonomic failure and is relieved by sitting or lying flat.12PubMed Central. Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension Researchers have attributed it to muscle hypoperfusion, meaning the neck muscles aren’t getting enough blood when the person is upright.13PubMed. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy However, some research suggests the relationship between blood pressure drops and this pain pattern is more complex than a simple one-to-one link, and the pathophysiology may involve additional factors beyond straightforward hypoperfusion.14PubMed. Coat-hanger ache in orthostatic hypotension
Pituitary Tumors and Autonomic Headache Lookalikes
One reason doctors take autonomic headaches seriously is that the full range of trigeminal autonomic cephalalgias has been described in association with pituitary tumors at a higher prevalence than in the general population.15Adv Clin Neurosci Rehabil. Pituitary headache The pituitary gland sits in a bony pocket at the base of the skull, near structures that can irritate the trigeminal and autonomic pathways when a growth presses against them. A headache that looks like cluster headache or paroxysmal hemicrania but doesn’t respond as expected to standard treatments, or that has atypical features, warrants brain imaging to rule out a structural cause. This doesn’t mean that most autonomic headaches are caused by tumors; they aren’t. But it’s a reminder that the diagnosis should be confirmed rather than assumed.
Treatments That Target Autonomic Pathways
Because the trigeminal-autonomic reflex is central to cluster headache and its relatives, several treatments have been designed to interrupt that reflex at different points.
The sphenopalatine ganglion (SPG) is a cluster of nerve cells located behind the nose that serves as a relay station for parasympathetic outflow to the face. It’s a natural target for autonomic headache treatment. A systematic review found the SPG to be a promising target using nerve blocks, radiofrequency ablation, and neurostimulation.16PubMed Central. Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation – a systematic review In a placebo-controlled study of patients with treatment-resistant chronic cluster headache, SPG stimulation provided pain relief in about two-thirds of treated attacks compared to just 7% with sham stimulation. Over 24 months, the effect held up, and roughly a third of patients saw their attack frequency drop by more than half, suggesting repeated stimulation might also work preventively.17PubMed Central. Managing cluster headache with sphenopalatine ganglion stimulation: a review
Non-invasive vagus nerve stimulation (nVNS) takes a different approach. The vagus nerve has extensive connections with the trigeminal system, and stimulating it through the skin of the neck can dampen pain-signaling neurons. Clinical experience and anatomical reviews have found nVNS to be moderately effective, safe, and well tolerated for primary headache disorders. Anatomical studies show that vagus nerve fibers intertwine with fibers from the trigeminal, facial, and glossopharyngeal nerves, mostly in the trigeminal spinal tract, providing a physical basis for how stimulating the vagus nerve could influence trigeminal pain circuits.18PubMed Central. Vagus nerve stimulation for primary headache disorders: An anatomical review to explain a clinical phenomenon The proposed mechanisms span several domains: regulating autonomic nervous system function, inhibiting cortical spreading depression (a wave of brain activity implicated in migraine aura), adjusting neurotransmitter levels, and dampening pain signaling.19PubMed. Non-invasive vagus nerve stimulation for primary headache: A clinical update In animal models of cluster-like head pain, transcutaneous vagus nerve stimulation suppressed pain-related neuron firing and reduced levels of the excitatory neurotransmitter glutamate in pain-processing regions of the brainstem.20PubMed Central. Non‐Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline
Deep Brain Stimulation for the Most Severe Cases
When cluster headache resists all available medications and less invasive neuromodulation, deep brain stimulation (DBS) of the posterior hypothalamus has emerged as a last-resort option. The rationale follows directly from the observation that the hypothalamus is the apparent generator of cluster attacks. The first cases showed that electrical stimulation of the ipsilateral posterior inferior hypothalamus could produce complete, long-term pain relief with no relevant side effects.21PubMed. Hypothalamic deep brain stimulation for intractable chronic cluster headache: a 3-year follow-up
Subsequent case series have been mixed but generally encouraging. In one series of six patients, four experienced a substantial decrease in attack frequency and pain intensity within the first six months, and three were nearly attack-free at an average follow-up of 17 months, though three were considered treatment failures.22PubMed. Hypothalamic deep brain stimulation for cluster headache: experience from a new multicase series A broader review of the literature found that DBS alleviated pain in a majority of patients through targeting of the posterior hypothalamus or the ventral tegmental area, with a minimal side-effect profile.23PubMed. Deep Brain Stimulation for Chronic Cluster Headache: A Review DBS remains reserved for patients who have exhausted every other option. The procedure involves implanting electrodes in the brain, which carries inherent surgical risks, and the response rate, while promising, is not universal.
Genetic and Familial Patterns
Cluster headache tends to run in families, though not as strongly as some other neurological conditions. A systematic review found that the rate of family history among cluster headache patients ranged from 0% to 22%, with a median of about 8%. When researchers traced inheritance patterns across 67 family pedigrees, roughly 69% were consistent with an autosomal dominant pattern and 28% with an autosomal recessive pattern.24PubMed Central. Family History of Cluster Headache: A Systematic Review
The genetic architecture is becoming clearer. A large genome-wide association study estimated that common genetic variants account for about 14.5% of cluster headache risk and identified eight genomic regions linked to the condition. The study also used a statistical technique to test whether smoking is merely correlated with cluster headache or causally involved, and the results implicated smoking as a causal risk factor.25PubMed. Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor This finding is relevant for patients because cluster headache has long been associated with heavy smoking, but the directionality was uncertain. The genetic evidence suggests that quitting smoking may genuinely reduce risk or disease burden rather than the association being purely coincidental.
Hormones and the Sex Disparity
Cluster headache is three to four times more common in men than women, a disparity that has led researchers to investigate hormonal influences. Testosterone, in particular, has been a focus because levels tend to be lower in men with cluster headache during active periods. But the relationship is tangled: it’s hard to know whether altered hormone levels drive the headache or the headache disrupts hormonal regulation through the hypothalamus, which controls both.
An unusual case report recently offered a suggestive data point. A patient with chronic, treatment-resistant cluster headache experienced significant improvement after starting gender-affirming hormonal treatment with cyproterone acetate (an antiandrogen) and estradiol. The authors noted that the case adds to a growing body of literature suggesting hormonal factors may influence the clinical course of cluster headache, and that hormonal modulation might offer an adjunct approach for managing chronic, treatment-resistant cases.26SAGE Journals / Cephalalgia Reports. Case report: A case of chronic cluster headache affected by gender affirmation treatment A single case report can’t establish a treatment principle, but it fits with broader observations about the hypothalamic-hormonal axis playing a role in cluster headache biology. Future research exploring sex hormones and headache more systematically could open up treatment avenues for patients who don’t respond to conventional approaches.